2019

Rheonix Inc. Files 510(k) Seeking FDA Clearance of Triplex Sexually Transmitted Infection Assay

ITHACA, N.Y. — Rheonix, Inc. Rheonix filed its first 510(k) on November 4, seeking to gain FDA clearance of its Rheonix STI TriPlex™ Assay (a PCR-based assay for the simultaneous detection for Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis) as well as the Rheonix Encompass MDx® Workstation, a fully automated “sample-to-answer” system capable of taking untreated clinical specimens and extracting, purifying and PCR amplifying DNA targets.  In addition the 510(k) filing… Read More »

Rheonix Inc. and Mérieux NutriSciences Announce the Successful Conclusion of Early-Access Listeria PatternAlert™ Assay Evaluation

Method Enables Food Producers to Rapidly Identify and Address Recurring Listeria in Facilities ITHACA, N.Y. — Rheonix Inc. and Mérieux NutriSciences announce the successful conclusion of early-access customer evaluations of the Listeria PatternAlert™ assay, a breakthrough method for rapidly identifying molecular patterns from Listeria strains. The method assists food producers in identifying harborage sites for persistent Listeria and in tracing back sources of contamination. Results are available at roughly half the cost… Read More »
Rheonix is working to address the Coronavirus pandemic with our fully automated testing technology.
Click here for timely COVID-19 news and updates